TransMedics Group Financial Overview
TransMedics Group's market cap is currently $4.36B. The company's EPS TTM is $0.66; its P/E ratio is 51.57; TransMedics Group is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.
